BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 12778480)

  • 21. A novel strategy for the discovery of MHC class II-restricted tumor antigens: identification of a melanotransferrin helper T-cell epitope.
    Röhn TA; Reitz A; Paschen A; Nguyen XD; Schadendorf D; Vogt AB; Kropshofer H
    Cancer Res; 2005 Nov; 65(21):10068-78. PubMed ID: 16267033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation activates self hsp60-specific T cells.
    Anderton SM; van der Zee R; Goodacre JA
    Eur J Immunol; 1993 Jan; 23(1):33-8. PubMed ID: 7678230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
    Estaquier J; Boutillon C; Georges B; Ameisen JC; Tartar A; Auriault C
    J Pept Sci; 1996; 2(3):165-75. PubMed ID: 9231325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo T helper cell response to retro-inverso peptidomimetics.
    Mézière C; Viguier M; Dumortier H; Lo-Man R; Leclerc C; Guillet JG; Briand JP; Muller S
    J Immunol; 1997 Oct; 159(7):3230-7. PubMed ID: 9317121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ImMucin: a novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors.
    Kovjazin R; Volovitz I; Kundel Y; Rosenbaum E; Medalia G; Horn G; Smorodinsky NI; Brenner B; Carmon L
    Vaccine; 2011 Jun; 29(29-30):4676-86. PubMed ID: 21570434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells.
    Abdel-Motal UM; Berg L; Rosén A; Bengtsson M; Thorpe CJ; Kihlberg J; Dahmén J; Magnusson G; Karlsson KA; Jondal M
    Eur J Immunol; 1996 Mar; 26(3):544-51. PubMed ID: 8605919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes.
    Ninkovic T; Kinarsky L; Engelmann K; Pisarev V; Sherman S; Finn OJ; Hanisch FG
    Mol Immunol; 2009 Nov; 47(1):131-40. PubMed ID: 19007994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHC-unrestricted lysis of MUC1-expressing cells by human peripheral blood mononuclear cells.
    Wright SE; Rewers-Felkins KA; Quinlin IS; Fogler WE; Phillips CA; Townsend M; Robinson W; Philip R
    Immunol Invest; 2008; 37(3):215-25. PubMed ID: 18389441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4+ T helper cell response is required for memory in CD8+ T lymphocytes induced by a poly(I:C)-adjuvanted MHC I-restricted peptide epitope.
    Qiu F; Cui Z
    J Immunother; 2007; 30(2):180-9. PubMed ID: 17471165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MUC1 peptide epitopes associated with five different H-2 class I molecules.
    Apostolopoulos V; Haurum JS; McKenzie IF
    Eur J Immunol; 1997 Oct; 27(10):2579-87. PubMed ID: 9368613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.
    Guan HH; Budzynski W; Koganty RR; Krantz MJ; Reddish MA; Rogers JA; Longenecker BM; Samuel J
    Bioconjug Chem; 1998; 9(4):451-8. PubMed ID: 9667946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycopeptides bind MHC molecules and elicit specific T cell responses.
    Harding CV; Kihlberg J; Elofsson M; Magnusson G; Unanue ER
    J Immunol; 1993 Sep; 151(5):2419-25. PubMed ID: 8360471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Water-soluble polymers coupled with glycopeptide antigens and T-cell epitopes as potential antitumor vaccines.
    Nuhn L; Hartmann S; Palitzsch B; Gerlitzki B; Schmitt E; Zentel R; Kunz H
    Angew Chem Int Ed Engl; 2013 Sep; 52(40):10652-6. PubMed ID: 24038824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbohydrate and peptide specificity of MHC class II-restricted T cell hybridomas raised against an O-glycosylated self peptide.
    Jensen T; Hansen P; Galli-Stampino L; Mouritsen S; Frische K; Meinjohanns E; Meldal M; Werdelin O
    J Immunol; 1997 Apr; 158(8):3769-78. PubMed ID: 9103442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and immunological evaluation of self-assembling and self-adjuvanting tricomponent glycopeptide cancer-vaccine candidates.
    Wilkinson BL; Day S; Chapman R; Perrier S; Apostolopoulos V; Payne RJ
    Chemistry; 2012 Dec; 18(51):16540-8. PubMed ID: 23090901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region.
    Shirai M; Arichi T; Chen M; Masaki T; Nishioka M; Ikeda K; Takahashi H; Enomoto N; Saito T; Major ME; Nakazawa T; Akatsuka T; Feinstone SM; Berzofsky JA
    J Immunol; 1999 Jan; 162(1):568-76. PubMed ID: 9886434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition.
    Haurum JS; Tan L; Arsequell G; Frodsham P; Lellouch AC; Moss PA; Dwek RA; McMichael AJ; Elliott T
    Eur J Immunol; 1995 Dec; 25(12):3270-6. PubMed ID: 8566011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner.
    Kobayashi H; Nagato T; Sato K; Aoki N; Kimura S; Murakami M; Iizuka H; Azumi M; Kakizaki H; Tateno M; Celis E
    Cancer Res; 2007 Jun; 67(11):5498-504. PubMed ID: 17545632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.